文献速递心力衰竭与心肌病心律失常

NOD1通过调控钙离子处理在心力衰竭进展中的作用

Role of NOD1 in Heart Failure Progression via Regulation of Ca2+ Handling.
PubMed 文献 · J Am Coll Cardiol · 2017-01-01

该研究在人类衰竭心肌和心肌梗死后心力衰竭小鼠模型中检测NOD1的作用,发现NOD1通路在人类和小鼠衰竭心肌中上调;与野生型心肌梗死后心衰小鼠相比,Nod1敲除小鼠心功能更好、结构重构减轻,且钙离子动力学障碍、室性心律失常和死亡率均降低,提示NOD1通过调控细胞内钙离子处理参与心衰进展,可能成为心衰治疗新靶点。

要点

  • NOD1通路在人类和小鼠衰竭心肌中上调。
  • Nod1敲除改善心肌梗死后心衰小鼠的心功能和结构重构。
  • NOD1调控细胞内钙离子处理障碍,可能成为心衰治疗新靶点。

核心结论

  • NOD1调控心力衰竭中的细胞内钙离子处理障碍,可能成为心衰治疗的新靶点。

研究设计与样本

  • 在人类衰竭心肌和心肌梗死后心力衰竭小鼠模型中检测NOD1,比较野生型(wt-PMI)与Nod1敲除(Nod1-/--PMI)小鼠。

主要发现

  • NOD1通路在人类和小鼠衰竭心肌中上调。
  • 与wt-PMI小鼠相比,Nod1-/--PMI小鼠心功能更好且结构重构减轻。
  • Nod1-/--PMI小鼠心功能改善与预防心衰相关的钙离子动力学障碍有关,包括细胞内钙浓度瞬变幅度更小、持续时间更长,以及因肌浆网钙ATP酶泵下调、Na+/Ca2+交换体水平升高导致的肌浆网钙负荷减少。
  • wt-PMI心肌细胞舒张期钙释放增加与兰尼碱受体超磷酸化有关,而Nod1-/--PMI心肌细胞中该超磷酸化被减弱。
  • 药物阻断NOD1也可预防wt-PMI小鼠的钙离子处理异常。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Heart failure (HF) is a complex syndrome associated with a maladaptive innate immune system response that leads to deleterious cardiac remodeling. However, the underlying mechanisms of this syndrome are poorly understood. Nucleotide-binding oligomerization domain-containing protein 1 (NOD1) is a newly recognized innate immune sensor involved in cardiovascular diseases. OBJECTIVES: This study evaluated the role of NOD1 in HF progression. METHODS: NOD1 was examined in human failing myocardium and in a post-myocardial infarction (PMI) HF model evaluated in wild-type (wt-PMI) and Nod1-/- mice (Nod1-/--PMI). RESULTS: The NOD1 pathway was up-regulated in human and murine failing myocardia. Compared with wt-PMI, hearts from Nod1-/--PMI mice had better cardiac function and attenuated structural remodeling. Ameliorated cardiac function in Nod1-/--PMI mice was associated with prevention of Ca2+ dynamic impairment linked to HF, including smaller and longer intracellular Ca2+ concentration transients and a lesser sarcoplasmic reticulum Ca2+ load due to a down-regulation of the sarcoplasmic reticulum Ca2+-adenosine triphosphatase pump and by augmented levels of the Na+/Ca2+ exchanger. Increased diastolic Ca2+ release in wt-PMI cardiomyocytes was related to hyperphosphorylation of ryanodine receptors, which was blunted in Nod1-/--PMI cardiomyocytes. Pharmacological blockade of NOD1 also prevented Ca2+ mishandling in wt-PMI mice. Nod1-/--PMI mice showed significantly fewer ventricular arrhythmias and lower mortality after isoproterenol administration. These effects were associated with lower aberrant systolic Ca2+ release and with a prevention of the hyperphosphorylation of ryanodine receptors under isoproterenol administration in Nod1-/--PMI mice. CONCLUSIONS: NOD1 modulated intracellular Ca2+ mishandling in HF, emerging as a new target for HF therapy.

来源:J Am Coll Cardiol,查看原文。版权归原作者所有。

引用

  1. Val-Blasco A, Piedras MJGM, Ruiz-Hurtado G, et al. Role of NOD1 in Heart Failure Progression via Regulation of Ca2+ Handling. J Am Coll Cardiol. 2017. PMID: 28126160. doi:10.1016/j.jacc.2016.10.073

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。